{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:55:40Z","timestamp":1791939340116,"version":"4.3.4"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T00:00:00Z","timestamp":1506643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1038\/cdd.2017.150","type":"journal-article","created":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T13:29:55Z","timestamp":1506691795000},"page":"241-254","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Coordinated repression of BIM and PUMA by Epstein\u2013Barr virus latent genes maintains the survival of Burkitt lymphoma cells"],"prefix":"10.1038","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7401-0186","authenticated-orcid":false,"given":"Leah","family":"Fitzsimmons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J","family":"Boyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1288-6999","authenticated-orcid":false,"given":"Wenbin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Croom-Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary J","family":"Tierney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco J","family":"Herold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew I","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Strasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma L","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,29]]},"reference":[{"key":"BFcdd2017150_CR1","doi-asserted-by":"crossref","unstructured":"Magrath I . Epidemiology: clues to the pathogenesis of Burkitt lymphoma. Br J Haematol 2012.","DOI":"10.1111\/j.1365-2141.2011.09013.x"},{"key":"BFcdd2017150_CR2","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/nrc904","volume":"2","author":"S Pelengaris","year":"2002","unstructured":"Pelengaris S, Khan M, Evan G . c-MYC: more than just a matter of life and death. Nat Rev Cancer 2002; 2: 764\u2013776.","journal-title":"Nat Rev Cancer"},{"key":"BFcdd2017150_CR3","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1038\/emboj.2011.307","volume":"30","author":"A Strasser","year":"2011","unstructured":"Strasser A, Cory S, Adams JM . Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases. EMBO J 2011; 30: 3667\u20133683.","journal-title":"EMBO J"},{"key":"BFcdd2017150_CR4","doi-asserted-by":"publisher","first-page":"6164","DOI":"10.1073\/pnas.0401471101","volume":"101","author":"A Egle","year":"2004","unstructured":"Egle A, Harris AW, Bouillet P, Cory S . Bim is a suppressor of Myc-induced mouse B cell leukemia. Proc Natl Acad Sci USA 2004; 101: 6164\u20136169.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcdd2017150_CR5","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/cdd.2008.195","volume":"16","author":"EM Michalak","year":"2009","unstructured":"Michalak EM, Jansen ES, Happo L, Cragg MS, Tai L, Smyth GK et al. Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis. Cell Death Differ 2009; 16: 684\u2013696.","journal-title":"Cell Death Differ"},{"key":"BFcdd2017150_CR6","doi-asserted-by":"publisher","first-page":"5256","DOI":"10.1182\/blood-2010-04-280818","volume":"116","author":"L Happo","year":"2010","unstructured":"Happo L, Cragg MS, Phipson B, Haga JM, Jansen ES, Herold MJ et al. Maximal killing of lymphoma cells by DNA damage-inducing therapy requires not only the p53 targets Puma and Noxa, but also Bim. Blood 2010; 116: 5256\u20135267.","journal-title":"Blood"},{"key":"BFcdd2017150_CR7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/348331a0","volume":"348","author":"A Strasser","year":"1990","unstructured":"Strasser A, Harris AW, Bath ML, Cory S . Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature 1990; 348: 331\u2013333.","journal-title":"Nature"},{"key":"BFcdd2017150_CR8","first-page":"609","volume":"33","author":"M Rowe","year":"2014","unstructured":"Rowe M, Fitzsimmons L, Bell AI . Epstein\u2013Barr virus and Burkitt lymphoma. Chin J Cancer 2014; 33: 609\u2013619.","journal-title":"Chin J Cancer"},{"key":"BFcdd2017150_CR9","doi-asserted-by":"publisher","first-page":"10709","DOI":"10.1128\/JVI.79.16.10709-10717.2005","volume":"79","author":"GL Kelly","year":"2005","unstructured":"Kelly GL, Milner AE, Tierney RJ, Croom-Carter DS, Altmann M, Hammerschmidt W et al. Epstein\u2013Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis. J Virol 2005; 79: 10709\u201310717.","journal-title":"J Virol"},{"key":"BFcdd2017150_CR10","doi-asserted-by":"publisher","first-page":"14935","DOI":"10.1073\/pnas.0509988103","volume":"103","author":"GL Kelly","year":"2006","unstructured":"Kelly GL, Milner AE, Baldwin GS, Bell AI, Rickinson AB . Three restricted forms of Epstein\u2013Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells. Proc Natl Acad Sci USA 2006; 103: 14935\u201314940.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcdd2017150_CR11","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/sj.onc.1210668","volume":"27","author":"E Anderton","year":"2008","unstructured":"Anderton E, Yee J, Smith P, Crook T, White RE, Allday MJ . Two Epstein\u2013Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma. Oncogene 2008; 27: 421\u2013433.","journal-title":"Oncogene"},{"key":"BFcdd2017150_CR12","doi-asserted-by":"publisher","first-page":"e1001236","DOI":"10.1371\/journal.ppat.1001236","volume":"6","author":"M Kvansakul","year":"2010","unstructured":"Kvansakul M, Wei AH, Fletcher JI, Willis SN, Chen L, Roberts AW et al. Structural basis for apoptosis inhibition by Epstein\u2013Barr virus BHRF1. PLoS Pathog 2010; 6: e1001236.","journal-title":"PLoS Pathog"},{"key":"BFcdd2017150_CR13","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/ajcp\/aqv011","volume":"145","author":"T Amato","year":"2016","unstructured":"Amato T, Abate F, Piccaluga P, Iacono M, Fallerini C, Renieri A et al. Clonality analysis of immunoglobulin gene rearrangement by next-generation sequencing in endemic Burkitt lymphoma suggests antigen drive activation of BCR as opposed to sporadic Burkitt lymphoma. Am J Clin Pathol 2016; 145: 116\u2013127.","journal-title":"Am J Clin Pathol"},{"key":"BFcdd2017150_CR14","doi-asserted-by":"publisher","first-page":"e1005158","DOI":"10.1371\/journal.ppat.1005158","volume":"11","author":"F Abate","year":"2015","unstructured":"Abate F, Ambrosio MR, Mundo L, Laginestra MA, Fuligni F, Rossi M et al. Distinct viral and mutational spectrum of endemic Burkitt lymphoma. PLoS Pathog 2015; 11: e1005158.","journal-title":"PLoS Pathog"},{"key":"BFcdd2017150_CR15","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1182\/blood.V77.7.1516.1516","volume":"77","author":"B Shiramizu","year":"1991","unstructured":"Shiramizu B, Barriga F, Neequaye J, Jafri A, Dalla-Favera R, Neri A et al. Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein\u2013Barr virus association. Blood 1991; 77: 1516\u20131526.","journal-title":"Blood"},{"key":"BFcdd2017150_CR16","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1073\/pnas.83.9.2984","volume":"83","author":"PG Pelicci","year":"1986","unstructured":"Pelicci PG, Knowles DM, Magrath I, Dalla-Favera R . Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma. Proc Natl Acad Sci USA 1986; 83: 2984\u20132988.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcdd2017150_CR17","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1182\/blood-2010-05-285791","volume":"117","author":"DT Vereide","year":"2011","unstructured":"Vereide DT, Sugden B . Lymphomas differ in their dependence on Epstein\u2013Barr virus. Blood 2011; 117: 1977\u20131985.","journal-title":"Blood"},{"key":"BFcdd2017150_CR18","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1038\/onc.2013.71","volume":"33","author":"DT Vereide","year":"2014","unstructured":"Vereide DT, Seto E, Chiu YF, Hayes M, Tagawa T, Grundhoff A et al. Epstein\u2013Barr virus maintains lymphomas via its miRNAs. Oncogene 2014; 33: 1258\u20131264.","journal-title":"Oncogene"},{"key":"BFcdd2017150_CR19","doi-asserted-by":"publisher","first-page":"14269","DOI":"10.1073\/pnas.2336099100","volume":"100","author":"G Kennedy","year":"2003","unstructured":"Kennedy G, Komano J, Sugden B . Epstein\u2013Barr virus provides a survival factor to Burkitt's lymphomas. Proc Natl Acad Sci USA 2003; 100: 14269\u201314274.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcdd2017150_CR20","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1128\/JVI.71.3.1766-1775.1997","volume":"71","author":"AL Kirchmaier","year":"1997","unstructured":"Kirchmaier AL, Sugden B . Dominant-negative inhibitors of EBNA-1 of Epstein\u2013Barr virus. J Virol 1997; 71: 1766\u20131775.","journal-title":"J Virol"},{"key":"BFcdd2017150_CR21","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1086\/515290","volume":"177","author":"J Chodosh","year":"1998","unstructured":"Chodosh J, Holder VP, Gan YJ, Belgaumi A, Sample J, Sixbey JW . Eradication of latent Epstein\u2013Barr virus by hydroxyurea alters the growth-transformed cell phenotype. J Infect Dis 1998; 177: 1194\u20131201.","journal-title":"J Infect Dis"},{"key":"BFcdd2017150_CR22","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1128\/JVI.68.9.6069-6073.1994","volume":"68","author":"N Shimizu","year":"1994","unstructured":"Shimizu N, Tanabe-Tochikura A, Kuroiwa Y, Takada K . Isolation of Epstein\u2013Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV. J Virol 1994; 68: 6069\u20136073.","journal-title":"J Virol"},{"key":"BFcdd2017150_CR23","doi-asserted-by":"publisher","first-page":"4875","DOI":"10.1158\/0008-5472.CAN-12-2217","volume":"72","author":"C Swanton","year":"2012","unstructured":"Swanton C . Intratumor heterogeneity: evolution through space and time. Cancer Res 2012; 72: 4875\u20134882.","journal-title":"Cancer Res"},{"key":"BFcdd2017150_CR24","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/cas.12442","volume":"105","author":"M Suguro","year":"2014","unstructured":"Suguro M, Yoshida N, Umino A, Kato H, Tagawa H, Nakagawa M et al. Clonal heterogeneity of lymphoid malignancies correlates with poor prognosis. Cancer Sci 2014; 105: 897\u2013904.","journal-title":"Cancer Sci"},{"key":"BFcdd2017150_CR25","doi-asserted-by":"publisher","first-page":"10223","DOI":"10.1128\/JVI.74.21.10223-10228.2000","volume":"74","author":"IK Ruf","year":"2000","unstructured":"Ruf IK, Rhyne PW, Yang C, Cleveland JL, Sample JT . Epstein\u2013Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis. J Virol 2000; 74: 10223\u201310228.","journal-title":"J Virol"},{"key":"BFcdd2017150_CR26","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1002\/j.1460-2075.1991.tb07837.x","volume":"10","author":"PJ Farrell","year":"1991","unstructured":"Farrell PJ, Allan GJ, Shanahan F, Vousden KH, Crook T . p53 is frequently mutated in Burkitt's lymphoma cell lines. EMBO J 1991; 10: 2879\u20132887.","journal-title":"EMBO J"},{"key":"BFcdd2017150_CR27","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1182\/blood.V79.12.3300.bloodjournal79123300","volume":"79","author":"MH Falk","year":"1992","unstructured":"Falk MH, Trauth BC, Debatin KM, Klas C, Gregory CD, Rickinson AB et al. Expression of the Apo-1 antigen in Burkitt-lymphoma cell-lines correlates with a shift towards a lymphoblastoid phenotype. Blood 1992; 79: 3300\u20133306.","journal-title":"Blood"},{"key":"BFcdd2017150_CR28","doi-asserted-by":"crossref","first-page":"9827","DOI":"10.1128\/JVI.73.12.9827-9831.1999","volume":"73","author":"J Komano","year":"1999","unstructured":"Komano J, Maruo S, Kurozumi K, Oda T, Takada K . Oncogenic role of Epstein\u2013Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata. J Virol 1999; 73: 9827\u20139831.","journal-title":"J Virol"},{"key":"BFcdd2017150_CR29","doi-asserted-by":"crossref","first-page":"9150","DOI":"10.1128\/JVI.72.11.9150-9156.1998","volume":"72","author":"J Komano","year":"1998","unstructured":"Komano J, Sugiura M, Takada K . Epstein\u2013Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata. J Virol 1998; 72: 9150\u20139156.","journal-title":"J Virol"},{"key":"BFcdd2017150_CR30","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1128\/MCB.19.3.1651","volume":"19","author":"IK Ruf","year":"1999","unstructured":"Ruf IK, Rhyne PW, Yang H, Borza CM, Hutt-Fletcher LM, Cleveland JL et al. Epstein\u2013Barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma. Mol Cell Biol 1999; 19: 1651\u20131660.","journal-title":"Mol Cell Biol"},{"key":"BFcdd2017150_CR31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.virol.2010.10.029","volume":"410","author":"J Lu","year":"2011","unstructured":"Lu J, Murakami M, Verma SC, Cai QL, Haldar S, Kaul R et al. Epstein\u2013Barr virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivin. Virology 2011; 410: 64\u201375.","journal-title":"Virology"},{"key":"BFcdd2017150_CR32","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.3390\/v4091537","volume":"4","author":"L Frappier","year":"2012","unstructured":"Frappier L . Contributions of Epstein\u2013Barr nuclear antigen 1 (EBNA1) to cell immortalization and survival. Viruses 2012; 4: 1537\u20131547.","journal-title":"Viruses"},{"key":"BFcdd2017150_CR33","doi-asserted-by":"publisher","first-page":"e1005344","DOI":"10.1371\/journal.ppat.1005344","volume":"11","author":"X Lin","year":"2015","unstructured":"Lin X, Tsai MH, Shumilov A, Poirey R, Bannert H, Middeldorp JM et al. The Epstein\u2013Barr virus BART miRNA cluster of the M81 strain modulates multiple functions in primary B cells. PLoS Pathog 2015; 11: e1005344.","journal-title":"PLoS Pathog"},{"key":"BFcdd2017150_CR34","doi-asserted-by":"publisher","first-page":"18507","DOI":"10.1073\/pnas.0806213105","volume":"105","author":"MJ Herold","year":"2008","unstructured":"Herold MJ, van den Brandt J, Seibler J, Reichardt HM . Inducible and reversible gene silencing by stable integration of an shRNA-encoding lentivirus in transgenic rats. Proc Natl Acad Sci USA 2008; 105: 18507\u201318512.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcdd2017150_CR35","doi-asserted-by":"publisher","first-page":"6742","DOI":"10.1093\/emboj\/19.24.6742","volume":"19","author":"N Kitagawa","year":"2000","unstructured":"Kitagawa N, Goto M, Kurozumi K, Maruo S, Fukayama M, Naoe T et al. Epstein\u2013Barr virus-encoded poly(A)(\u2212) RNA supports Burkitt's lymphoma growth through interleukin-10 induction. EMBO J 2000; 19: 6742\u20136750.","journal-title":"EMBO J"},{"key":"BFcdd2017150_CR36","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1084\/jem.20072581","volume":"205","author":"EY Choy","year":"2008","unstructured":"Choy EY, Siu KL, Kok KH, Lung RW, Tsang CM, To KF et al. An Epstein\u2013Barr virus-encoded microRNA targets PUMA to promote host cell survival. J Exp Med 2008; 205: 2551\u20132560.","journal-title":"J Exp Med"},{"key":"BFcdd2017150_CR37","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.virol.2011.01.028","volume":"412","author":"AR Marquitz","year":"2011","unstructured":"Marquitz AR, Mathur A, Nam CS, Raab-Traub N . The Epstein\u2013Barr virus BART microRNAs target the pro-apoptotic protein Bim. Virology 2011; 412: 392\u2013400.","journal-title":"Virology"},{"key":"BFcdd2017150_CR38","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.1128\/JVI.75.10.4929-4935.2001","volume":"75","author":"P Trivedi","year":"2001","unstructured":"Trivedi P, Spinsanti P, Cuomo L, Volpe M, Takada K, Frati L et al. Differential regulation of Epstein\u2013Barr virus (EBV) latent gene expression in Burkitt lymphoma cells infected with a recombinant EBV strain. J Virol 2001; 75: 4929\u20134935.","journal-title":"J Virol"},{"key":"BFcdd2017150_CR39","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1128\/JVI.65.3.1245-1254.1991","volume":"65","author":"EA Hurley","year":"1991","unstructured":"Hurley EA, Agger S, McNeil JA, Lawrence JB, Calendar A, Lenoir G et al. When Epstein\u2013Barr virus persistently infects B-cell lines, it frequently integrates. J Virol 1991; 65: 1245\u20131254.","journal-title":"J Virol"},{"key":"BFcdd2017150_CR40","doi-asserted-by":"publisher","first-page":"7004","DOI":"10.1128\/JVI.78.13.7004-7015.2004","volume":"78","author":"T Kanda","year":"2004","unstructured":"Kanda T, Yajima M, Ahsan N, Tanaka M, Takada K . Production of high-titer Epstein\u2013Barr virus recombinants derived from Akata cells by using a bacterial artificial chromosome system. J Virol 2004; 78: 7004\u20137015.","journal-title":"J Virol"},{"key":"BFcdd2017150_CR41","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1128\/JVI.03300-14","volume":"89","author":"RJ Tierney","year":"2015","unstructured":"Tierney RJ, Nagra J, Rowe M, Bell AI, Rickinson AB . The Epstein\u2013Barr virus BamHI C promoter is not essential for B cell immortalization in vitro, but it greatly enhances B cell growth transformation. J Virol 2015; 89: 2483\u20132493.","journal-title":"J Virol"},{"key":"BFcdd2017150_CR42","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0092-8674(80)90173-7","volume":"22","author":"N Raab-Traub","year":"1980","unstructured":"Raab-Traub N, Dambaugh T, Kieff E . DNA of Epstein\u2013Barr virus VIII: B95-8, the previous prototype, is an unusual deletion derivative. Cell 1980; 22: 257\u2013267.","journal-title":"Cell"},{"key":"BFcdd2017150_CR43","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/JVI.35.3.603-618.1980","volume":"35","author":"GW Bornkamm","year":"1980","unstructured":"Bornkamm GW, Delius H, Zimber U, Hudewentz J, Epstein MA . Comparison of Epstein\u2013Barr virus strains of different origin by analysis of the viral DNAs. J Virol 1980; 35: 603\u2013618.","journal-title":"J Virol"},{"key":"BFcdd2017150_CR44","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.chom.2010.03.008","volume":"7","author":"L Dolken","year":"2010","unstructured":"Dolken L, Malterer G, Erhard F, Kothe S, Friedel CC, Suffert G et al. Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay. Cell Host Microbe 2010; 7: 324\u2013334.","journal-title":"Cell Host Microbe"},{"key":"BFcdd2017150_CR45","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/ijc.24655","volume":"126","author":"E Leucci","year":"2010","unstructured":"Leucci E, Onnis A, Cocco M, De Falco G, Imperatore F, Giuseppina A et al. B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression. Int J Cancer 2010; 126: 1316\u20131326.","journal-title":"Int J Cancer"},{"key":"BFcdd2017150_CR46","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/349612a0","volume":"349","author":"CD Gregory","year":"1991","unstructured":"Gregory CD, Dive C, Henderson S, Smith CA, Williams GT, Gordon J et al. Activation of Epstein\u2013Barr virus latent genes protects human B cells from death by apoptosis. Nature 1991; 349: 612\u2013614.","journal-title":"Nature"},{"key":"BFcdd2017150_CR47","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molcel.2004.12.030","volume":"17","author":"L Chen","year":"2005","unstructured":"Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG et al. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 2005; 17: 393\u2013403.","journal-title":"Mol Cell"},{"key":"BFcdd2017150_CR48","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1083\/jcb.200708096","volume":"180","author":"EF Lee","year":"2008","unstructured":"Lee EF, Czabotar PE, van Delft MF, Michalak EM, Boyle MJ, Willis SN et al. A novel BH3 ligand that selectively targets Mcl-1 reveals that apoptosis can proceed without Mcl-1 degradation. J Cell Biol 2008; 180: 341\u2013355.","journal-title":"J Cell Biol"},{"key":"BFcdd2017150_CR49","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/infdis\/173.3.529","volume":"173","author":"BI Razzouk","year":"1996","unstructured":"Razzouk BI, Srinivas S, Sample CE, Singh V, Sixbey JW . Epstein\u2013Barr Virus DNA recombination and loss in sporadic Burkitt's lymphoma. J Infect Dis 1996; 173: 529\u2013535.","journal-title":"J Infect Dis"},{"key":"BFcdd2017150_CR50","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3389\/fmicb.2017.00229","volume":"8","author":"L Mundo","year":"2017","unstructured":"Mundo L, Ambrosio MR, Picciolini M, Lo Bello G, Gazaneo S, Del Porro L et al. Unveiling another missing piece in EBV-driven lymphomagenesis: EBV-encoded microRNAs expression in EBER-negative Burkitt lymphoma cases. Front Microbiol 2017; 8: 229.","journal-title":"Front Microbiol"},{"key":"BFcdd2017150_CR51","doi-asserted-by":"publisher","first-page":"e1005701","DOI":"10.1371\/journal.ppat.1005701","volume":"12","author":"FR van Diemen","year":"2016","unstructured":"van Diemen FR, Kruse EM, Hooykaas MJ, Bruggeling CE, Schurch AC, van Ham PM et al. CRISPR\/Cas9-mediated genome editing of herpesviruses limits productive and latent infections. PLoS Pathog 2016; 12: e1005701.","journal-title":"PLoS Pathog"},{"key":"BFcdd2017150_CR52","doi-asserted-by":"publisher","first-page":"13053","DOI":"10.1128\/JVI.01521-10","volume":"84","author":"Z Lin","year":"2010","unstructured":"Lin Z, Xu G, Deng N, Taylor C, Zhu D, Flemington EK . Quantitative and qualitative RNA-Seq-based evaluation of Epstein\u2013Barr virus transcription in type I latency Burkitt's lymphoma cells. J Virol 2010; 84: 13053\u201313058.","journal-title":"J Virol"},{"key":"BFcdd2017150_CR53","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.virol.2014.10.030","volume":"474","author":"RJ Tierney","year":"2015","unstructured":"Tierney RJ, Shannon-Lowe CD, Fitzsimmons L, Bell AI, Rowe M . Unexpected patterns of Epstein\u2013Barr virus transcription revealed by a high throughput PCR array for absolute quantification of viral mRNA. Virology 2015; 474: 117\u2013130.","journal-title":"Virology"},{"key":"BFcdd2017150_CR54","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1038\/onc.2008.75","volume":"27","author":"M Samanta","year":"2008","unstructured":"Samanta M, Iwakiri D, Takada K . Epstein\u2013Barr virus-encoded small RNA induces IL-10 through RIG-I-mediated IRF-3 signaling. Oncogene 2008; 27: 4150\u20134160.","journal-title":"Oncogene"},{"key":"BFcdd2017150_CR55","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1038\/emboj.2012.63","volume":"31","author":"KJ Riley","year":"2012","unstructured":"Riley KJ, Rabinowitz GS, Yario TA, Luna JM, Darnell RB, Steitz JA . EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency. EMBO J 2012; 31: 2207\u20132221.","journal-title":"EMBO J"},{"key":"BFcdd2017150_CR56","doi-asserted-by":"publisher","first-page":"e1002484","DOI":"10.1371\/journal.ppat.1002484","volume":"8","author":"RL Skalsky","year":"2012","unstructured":"Skalsky RL, Corcoran DL, Gottwein E, Frank CL, Kang D, Hafner M et al. The viral and cellular microRNA targetome in lymphoblastoid cell lines. PLoS Pathog 2012; 8: e1002484.","journal-title":"PLoS Pathog"},{"key":"BFcdd2017150_CR57","doi-asserted-by":"publisher","first-page":"e0124638","DOI":"10.1371\/journal.pone.0124638","volume":"10","author":"G Pimienta","year":"2015","unstructured":"Pimienta G, Fok V, Haslip M, Nagy M, Takyar S, Steitz JA . Proteomics and transcriptomics of BJAB cells expressing the Epstein\u2013Barr virus noncoding RNAs EBER1 and EBER2. PLoS ONE 2015; 10: e0124638.","journal-title":"PLoS ONE"},{"key":"BFcdd2017150_CR58","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nature11378","volume":"490","author":"R Schmitz","year":"2012","unstructured":"Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 2012; 490: 116\u2013120.","journal-title":"Nature"},{"key":"BFcdd2017150_CR59","doi-asserted-by":"publisher","first-page":"5921","DOI":"10.1074\/jbc.M110.179101","volume":"286","author":"JL Coloff","year":"2011","unstructured":"Coloff JL, Mason EF, Altman BJ, Gerriets VA, Liu T, Nichols AN et al. Akt requires glucose metabolism to suppress puma expression and prevent apoptosis of leukemic T cells. J Biol Chem 2011; 286: 5921\u20135933.","journal-title":"J Biol Chem"},{"key":"BFcdd2017150_CR60","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1038\/sj.onc.1210496","volume":"26","author":"VH Wood","year":"2007","unstructured":"Wood VH, O'Neil JD, Wei W, Stewart SE, Dawson CW, Young LS . Epstein\u2013Barr virus-encoded EBNA1 regulates cellular gene transcription and modulates the STAT1 and TGFbeta signaling pathways. Oncogene 2007; 26: 4135\u20134147.","journal-title":"Oncogene"},{"key":"BFcdd2017150_CR61","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1182\/blood-2006-11-059881","volume":"111","author":"JR Flavell","year":"2008","unstructured":"Flavell JR, Baumforth KR, Wood VH, Davies GL, Wei W, Reynolds GM et al. Down-regulation of the TGF-beta target gene, PTPRK, by the Epstein\u2013Barr virus encoded EBNA1 contributes to the growth and survival of Hodgkin lymphoma cells. Blood 2008; 111: 292\u2013301.","journal-title":"Blood"},{"key":"BFcdd2017150_CR62","doi-asserted-by":"publisher","first-page":"16077","DOI":"10.1007\/s13277-016-5432-0","volume":"37","author":"B Wu","year":"2016","unstructured":"Wu B, Guo B, Kang J, Deng X, Fan Y, Zhang X et al. Downregulation of Smurf2 ubiquitin ligase in pancreatic cancer cells reversed TGF-beta-induced tumor formation. Tumour Biol 2016; 37: 16077\u201316091.","journal-title":"Tumour Biol"},{"key":"BFcdd2017150_CR63","doi-asserted-by":"publisher","first-page":"5198","DOI":"10.1074\/jbc.M112.410274","volume":"288","author":"LC Spender","year":"2012","unstructured":"Spender LC, Carter MJ, O'Brien DI, Clark LJ, Yu J, Michalak EM et al. Transforming growth factor-\u03b2 directly induces PUMA during the rapid induction of apoptosis in Myc-driven B-cell lymphomas. J Biol Chem 2012; 288: 5198\u20135209.","journal-title":"J Biol Chem"},{"key":"BFcdd2017150_CR64","doi-asserted-by":"publisher","first-page":"e0126645","DOI":"10.1371\/journal.pone.0126645","volume":"10","author":"E Papaianni","year":"2015","unstructured":"Papaianni E, El Maadidi S, Schejtman A, Neumann S, Maurer U, Marino-Merlo F et al. Phylogenetically distant viruses use the same BH3-only protein Puma to trigger Bax\/Bak-dependent apoptosis of infected mouse and human cells. PLoS ONE 2015; 10: e0126645.","journal-title":"PLoS ONE"},{"key":"BFcdd2017150_CR65","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/335440a0","volume":"335","author":"DL Vaux","year":"1988","unstructured":"Vaux DL, Cory S, Adams JM . Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988; 335: 440\u2013442.","journal-title":"Nature"},{"key":"BFcdd2017150_CR66","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.trecan.2016.07.001","volume":"2","author":"S Cory","year":"2016","unstructured":"Cory S, Roberts AW, Colman PM, Adams JM . Targeting BCL-2-like proteins to kill cancer cells. Trends Cancer 2016; 2: 443\u2013460.","journal-title":"Trends Cancer"},{"key":"BFcdd2017150_CR67","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.celrep.2015.02.002","volume":"10","author":"BJ Aubrey","year":"2015","unstructured":"Aubrey BJ, Kelly GL, Kueh AJ, Brennan MS, O'Connor L, Milla L et al. An inducible lentiviral guide RNA platform enables the identification of tumor-essential genes and tumor-promoting mutations in vivo. Cell Rep 2015; 10: 1422\u20131432.","journal-title":"Cell Rep"},{"key":"BFcdd2017150_CR68","doi-asserted-by":"publisher","first-page":"7749","DOI":"10.1128\/JVI.00108-09","volume":"83","author":"C Shannon-Lowe","year":"2009","unstructured":"Shannon-Lowe C, Adland E, Bell AI, Delecluse HJ, Rickinson AB, Rowe M . Features distinguishing Epstein\u2013Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification. J Virol 2009; 83: 7749\u20137760.","journal-title":"J Virol"},{"key":"BFcdd2017150_CR69","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.1128\/JVI.68.8.4716-4726.1994","volume":"68","author":"DR Martin","year":"1994","unstructured":"Martin DR, Marlowe RL, Ahearn JM . Determination of the role for CD21 during Epstein\u2013Barr virus infection of B-lymphoblastoid cells. J Virol 1994; 68: 4716\u20134726.","journal-title":"J Virol"}],"container-title":["Cell Death & Differentiation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cdd2017150.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cdd2017150","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/cdd.2017.150","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/cdd2017150.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T07:30:14Z","timestamp":1719473414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cdd2017150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,29]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["BFcdd2017150"],"URL":"https:\/\/doi.org\/10.1038\/cdd.2017.150","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.731430964.793566248","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.731430964.793537346","asserted-by":"object"}]},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,29]]},"assertion":[{"value":"14 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}